
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
GRBT | Paris | EUR | Real-time | |
0ELV | London | EUR | Real-time | |
GRBT | Frankfurt | EUR | Delayed |
Guerbet SA engages in the development and marketing of contrast media products, delivery systems, medical devices, and related solutions. The company offers Optiray and Xenetix, which are non-ionic monomeric and iodinated contrast agents; Telebrix Gastro, a meglumine ioxitalamate solution; Conray, an iothalamate meglumine injection; Micropaque/Microtrast, a diagnostic imaging interconnected solution; Dotarem, a gadoteric acid-gadoterate meglumine; Elucirem, a macrocyclic gadolinium-based contrast agent; and Artirem, a gadoteric acid that acts as a contrast agent for MRI, as well as prefilled syringes, injectors, accessories, and consumables for MRI, CT, and Cath Lab. It also provides digital solutions, such as OptiProtect services. In addition, the company provides products for interventional radiology, including Lipiodol ethyl esters of iodinated fatty acids of poppyseed oil; Vectorio, a mixing and injection system for conventional trans-arterial chemoembolization; and Patent Blue V, a blue dye. Further, it offers Qitexio, a lipiodol resistant medical devices consisting of medical syringes and a stopcock; Hydra Vision, a digital imaging system for urological, gastroenterological, and gynecological treatment, as well as planning and diagnostic procedures; and urology accessories and consumables, as well as HydraVision, a digital imaging system. Guerbet SA was incorporated in 1926 and is headquartered in Villepinte, France.
Name | Age | Since | Title |
---|---|---|---|
Michel Guerbet | - | 2001 | Honorary Chairman |
Hugues Lecat | - | 2024 | Chairman of the Board |
Nicolas Louvet | 49 | 2016 | Non-Independent Director |
Céline Lamort | 43 | 2015 | Non-Independent Director |
Olivier Fougère | 61 | 2021 | Employee Director |
Marc Massiot | 65 | 2021 | Non-Independent Director |
Carine Dagommer | 55 | 2022 | Non-Independent Director |
Eric Guerbet | 49 | 2017 | Non-Independent Director |
Eric Drape | 63 | 2025 | Independent Director |
Marie de La Simone | 51 | 2023 | Employee-Elected Director |
Michele Jeanine Lesieur | 66 | 2025 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review